öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÒüÕðÓî
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º510

ËùÊôԺУ£ºÏÃÃÅ´óѧ
ËùÊôԺϵ£ºÒ½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúÀíѧ
Ñо¿ÁìÓò£º ¸Î°©µÄ·¢Éú·¢Õ¹×ªÒÆ»úÀí
Ñо¿ÁìÓò£º ¸Î°©µÄ·¢Éú·¢Õ¹×ªÒÆ»úÀí [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºyinzy@xmu.edu.cn
ͨѶµØÖ·£º¸Îµ¨Òȼ²²¡¡¢Æ÷¹ÙÒÆÖ²


¿ÆÑй¤×÷ :

¾­¹ýÁ˹úÄÚÍâÑϸñ¡¢Õý¹æ¼°ÏµÍ³µÄÍâ¿ÆѵÁ·£¬Äܹ»ÊìÁ·µØÍê³ÉÆÕͨÍâ¿ÆÒÔ¼°¸Îµ¨ÒÈÍâ¿ÆµÄËùÓÐÊÖÊõ²Ù×÷¡£´ÓÒ½½ü¶þÊ®ÄêÀ´£¬Íê³É¸÷ÀàÍâ¿ÆÊÖÊõ½ü8000Àý¡£
1¡¢¾«ÓÚ¸ÎÔàÍâ¿ÆÊÖÊõ£ºÍê³É¸÷ÖÖÀàÐ͵ĸÎÔàÇгýÊõ½ü1500Àý£¬ÌرðÊǶÔÓÚ¸÷ÖÖ¸´ÔÓÐÍ¡¢¸ßΣÐ͸ΰ©µÄÇгýÊõ£¬ÓжÀµ½µÄ¼¼ÒÕºÍϵͳµÄ´¦Àí¼¼ÇÉ¡£ÔÚÇøÓòѪÁ÷×è¶Ï°ë¸Î¡¢Èý¸ÎÇгýÊõ¡¢·ÇѪÁ÷×è¶ÏÇé¿öϸΰ©ÇгýÊõ¡¢È«¸ÎѪÁ÷×è¶ÏÎÞѪÇиÎÊõ¡¢Î²×´Ò¶¸ÎÔàÖ×ÁöÇгýÊõ¼°½Ó½ü»òÇÖ·¸¸ÎÃŲ¿´óѪ¹ÜµÄ¸Î°©ÇгýÊõ·½Ãæ´ïµ½¹úÄÚÍâÏȽøˮƽ¡£Ä¿Ç°¸ÎÔàÊÖÊõ¿ÉÒÔ×öµ½°²È«¡¢»Ö¸´¿ì¡¢»ù±¾²»ÊäѪ¡¢µÍ·ÑÓá£ÓëÏÃÃÅ´óѧ¼ÆËã»úϵºÏ×÷¿ª·¢µÄ¡°¸Î°©ÊÖÊõ¼Æ»®ÏµÍ³¡±Òѳɹ¦ÉêÇëµ½¶àÏî¹ú¼ÒרÀû£¬²¢Ð½ü»ñÅúÒ½ÁÆÊÖÊõÆ÷еע²áÖ¤£¬±¾ÏµÍ³ÊǸÃÀ༼ÊõÔÚ¹úÄڳɹ¦¿ª·¢²¢ÔÚÁÙ´²ÍƹãÓ¦ÓõĵÚÒ»¼Ò¡£¸ÃϵͳÔÚ¸ÎÔàÊÖÊõÇ°¿ÉÒÔ½«»¼Õ߸ÎÔàµÄÈýά½á¹¹³ÉÏñ£¬½«Ö×ÁöÓë¸ÎÔàÄÚËùÓйܵÀ×éÖ¯µÄ¹ØϵÇå³þ³ÊÏÖÔÚÍâ¿ÆÒ½ÉúµÄÑÛÇ°£¬ÎªÖ×ÁöµÄ¾«×¼ÇгýÖƶ¨¿É¿¿µÄÊÖÊõ¼Æ»®£¬Í¨¹ý¸ÃÒÇÆ÷»¹¿ÉÒÔϵͳµØÆÀ¹ÀÊÖÊõµÄ¿ÉÐÐÐÔ¡¢°²È«ÐÔ£¬ÎªÎÒ¿ÆÄ¿Ç°¿ªÕ¹µÄ¾«×¼¸ÎÔàÍâ¿ÆÊÖÊõ´òÏÂÁËÁ¼ºÃµÄ»ù´¡¡£
2¡¢³¤ÓÚ΢´´Íâ¿ÆÊÖÊõ£ºÀûÓÿÆÊÒÖÖÀàÆëÈ«µÄÏȽøÒÇÆ÷£¬Ôڸε¨ÒȵÄ΢´´Íâ¿Æ·½Ãæ²»¶Ï̽Ë÷м¼Êõ£¬ÓÚÉÏÊÀ¼Í¾ÅÊ®Äê´úÔÚ±¾µØÇøÂÊÏÈ¿ªÕ¹µ¨ÄÒ΢´´ÊÖÊõ£¬ÖÁÄ¿Ç°£¬ÒÑÍê³É΢´´µ¨ÄÒÇгýÊõ½ü3000Àý£¬ÎÞÒ»Àý³öÏÖÑÏÖز¢·¢Ö¢£»´ËÍ⣬ÔÚ΢´´¸ÎÔàÖ×ÁöÊÖÊõ·½Ãæ×ßÔÚ¸£½¨Ê¡µÄÇ°ÁУ¬Ä¿Ç°ÒÑÍê³É¸÷Àà΢´´¸ÎÔàÇгýÊõ80ÓàÀý£¬ÌرðÊdz¬Éùµ¶½áºÏ³¬ÉùÈ黯ÎüÒýµ¶£¨CUSA£©Ç»¾µÏ¾«Ï¸¸ÎÔࣨÖ×Áö£©ÇгýÊõ£¬´ïµ½¹úÄÚÏȽøˮƽ¡£Î¢´´Æ¢ÇгýÊõÒÔ¼°Î¢´´µ¨×ܹÜ̽²éȡʯÊõÒÑ×÷ΪÕâÀàÊÖÊõµÄ³£¹æÊõʽ¿ªÕ¹£»½áºÏ±¾µØÇø¸ÎÑ׺ó¸ÎÓ²»¯ÃÅÂö¸ßѹ֢¸ß·¢µÄÌص㣬ÔÚÊ¡ÄÚÂÊÏȳɹ¦¿ªÕ¹¸¹Ç»¾µÏ¾ÞÆ¢Çгý²¢Ê³¹Üθµ×ÇúÕž²Âö¶ÏÁ÷Êõ¡£ÔÚ¸£½¨Ê¡Ê×ÏÈ¿ªÕ¹¾­Æêµ¥¿×¸¹Ç»¾µ¸ßÄѶÈÊÖÊõ£¬Ä¿Ç°ÒÑÍê³É¶àÀýµ¥¿×µ¨ÄÒÇгýÊõ¡¢µ¨µÀ̽²éÊõ¡¢µ¥¿×΢´´¸ÎÔàÖ×ÁöÇгýÊõ¡¢¸ÎÄÒÖ×ÉöÄÒÖ׿ª´°ÒýÁ÷ÊÖÊõµÈ£¬´øÁì¿ÆÊÒÕæÕý½øÈëµ½¡°Îް̺ۡ±Î¢´´ÃÀÈÝÊÖÊõʱ´ú¡£
3¡¢ÉÃÓÚµ¨Òȸ´ÔÓ°©Ö׵ĸùÖΣºµ¨¹Ü°©ÌرðÊǸÎÃŲ¿µ¨¹Ü°©µÄ¸ùÖÎÐÔÇгýÊõ£¬ÒÈÏÙ°©¸ùÖÎÐÔ£¨À©´ó»òѪ¹ÜÖؽ¨£©ÒÈÊ®¶þÖ¸³¦ÇгýÊõÊǸε¨ÒÈÍâ¿Æ×ÔÓ¡¢×îΣÏÕµÄÊÖÊõ£¬¾­¹ý¶àÄêµÄ̽Ë÷ºÍʵ¼ù£¬ÔÚÍê³ÉµÄ100ÓàÀýµ¨¹Ü°©ÊÖÊõÒÔ¼°½ü200ÀýµÄÒÈÏÙÖ×ÁöÊÖÊõÖУ¬´ÓÊÖÊõµÄ¾«Ï¸³Ì¶È£¬¸ùÖγ̶È¡¢ÊÖÊõµÄ²¢·¢Ö¢ÒÔ¼°ÊÖÊõºóµÄÔ¶ÆÚÁÆЧ±È½Ï¶¼´ïµ½»ò½Ó½ü¹úÄÚÏȽøˮƽ¡£
4¡¢Ç±ÐÄÓÚÒÆÖ²Íâ¿ÆÊÖÊõ£º¶àÄê´ÓÊÂÒÆÖ²Íâ¿ÆµÄÁÙ´²ÑÐÐ޺ͻù´¡Ñо¿£¬²ÎÓ벢ЭÖúÍê³É½ü200Àý¸ÎÒÆÖ²Êõ£¨°üÀ¨½ü30Àý»îÌå¸ÎÒÆÖ²Êõ£©¡¢¸Î³¦ÁªºÏÒÆÖ²Êõ¡¢Ð¡³¦ÒÆÖ²Êõ£¬ÒÈÏÙ¼°ÒȵºµÈÆ÷¹Ù¼°×éÖ¯ÒÆÖ²µÄÁÙ´²ÊÖÊõ¡£²Î¼ÓÁËÑÇÖÞÊ×ÀýÈËÌåС³¦ÒÆÖ²£¨1994£©ºÍÊ×Àý¸Î³¦ÁªºÏÒÆÖ²£¨2003£©Êõ¡£ÏµÍ³µØѧϰºÍÕÆÎÕÁ˶àÖÖÆ÷¹ÙÒÆÖ²µÄÊÖÊõ¼¼Êõ£¬Î§ÊÖÊõÆڵļàÖΣ¬¿¹ÅųâÒ©ÎïÖÎÁƺÍÒÆÖ²ÃâÒßѧÀíÂÛ¡£
´ËÍ⣺¾­¹ýÑо¿£¬²ÉÓþֲ¿Ñª¹ÜÒ©Îï¹àעм¼ÊõÖÎÁÆÖØÖ¢ÒÈÏÙÑ×È¡µÃÁËÁ¼ºÃµÄЧ¹û£»ÔÚ±¾µØÇøÂÊÏÈ¿ªÕ¹×ÔÌå¹ÇËè¸Éϸ°ûÒÆÖ²ÁªºÏÖÎÁƸÎÓ²»¯Ð¼¼Êõ¡£ÔÚ¸¹²¿Íâ¿ÆµÄ¸÷ÖÖ¸´ÔÓÐÍðü£¨³¦ðü£¬ÒÈðüºÍµ¨ðü£©µÄÖÎÁÆÒÔ¼°Íâ¿ÆÓªÑøÖ§³Ö·½Ã棬ΧÊÖÊõÆÚ²¡È˵ÄÕýÈ·´¦Àí·½Ãæ»ýÀÛÁ˷ḻµÄ¾­Ñ顣ĿǰΪÖлªÒ½Ñ§»á³¦ÄÚ³¦ÍâÓªÑø·Ö»áÈ«¹úÇàÄêίԱ¡¢Öйú¿¹°©Ð­»á¸Î°©·Ö»áÈ«¹úÇàÄêίԱ¡¢¸£½¨Ê¡Íâ¿Æѧ»áίԱ¡£

¿ÆÑй¤×÷£º
ÔÚ˶ʿ¡¢²©Ê¿ÒÔ¼°²©Ê¿ºóÑо¿½×¶Î¾­ÀúÁËϵͳµÄ¿ÆÑÐѵÁ·¡£Ôڸΰ©µÄ»ù´¡ºÍÁÙ´²Ó¦ÓÃÑо¿·½Ã桢С³¦ÒÆÖ²¡¢¸Î³¦ÁªºÏÒÆÖ²¡¢¸ÎÔàÒÆÖ²¡¢ÒȵºÏ¸°ûÒÆÖ²ÒÔ¼°ÒÆÖ²ÃâÒߺÍÖ×ÁöÃâÒßµÈÁìÓòÓнÏÇ°ÑصÄÑо¿¹¤×÷¡£ÔÚ¹úÄÚÊ״γɹ¦½¨Á¢ÁË´ó¶¯Îï¨D¨DÖíµÄ¸Î³¦ÁªºÏÒÆÖ²¶¯ÎïÄ£ÐÍ¡£Ä¿Ç°Ö÷³Ö°üÀ¨¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¨2Ï¡¢¡°973¡±×Ó¿ÎÌ⣨2Ï¡¢¡°Ê®Ò»Î塱¼°¡°Ê®¶þ¡±ÖØ´ó¸Î°©×¨Ïî×Ó¿ÎÌ⣨¸÷1ÏÒÔ¼°½ÌÓý²¿Áôѧ¹é¹úÈËÔ±»ù½ð¡¢¸£½¨Ê¡×ÔÈ»¿Æѧ»ù½ð¡¢ÏÃÃÅÊÐÖصã¿ÆÑлù½ðÔÚÄÚµÄ10ÓàÏî»ù½ð£¬¸öÈËÓµÓпÆÑо­·Ñ³¬¹ý500ÍòÔª¡£ÏȺ󷢱íÂÛÎÄ70Óàƪ£¬ÆäÖÐSCIÊÕ¼µÄÂÛÎÄ25ƪ¡£¿ÆÑгɹû»ñµÃÁ˸£½¨Ê¡¿Æ¼¼½ø²½¶þµÈ½±1Ï¸£½¨Ê¡Ò½Ñ§¿Æ¼¼ÈýµÈ½±1ÏÏÃÃÅÊпƼ¼½ø²½Ò»µÈ½±1Ïî¡¢¶þµÈ½±2ÏÈýµÈ½«1Ïî¡£2011Äê³É¹¦É걨²¢»ñÅú¡°ÏÃÃÅÊÐÏû»¯ÏµÍ³Ö×Áöת»¯Ò½Ñ§ÖصãʵÑéÊÒ¡±£¬Å¬Á¦Ì½Ë÷½«¿ÆÑгɹûÏòÁÙ´²Ó¦ÓÃת»¯µÄ;¾¶²¢È¡µÃÁËϵÁÐÍ»ÆÆ¡£

½Ìѧ¹¤×÷£º
¸Îµ¨Íâ¿Æ½ÌÑÐ×é×鳤£¬³Ðµ£²¢³öÉ«µØÍê³ÉÁËÄϾ©´óѧҽѧԺ¡¢ÏÃÃÅ´óѧҽѧԺ¡¢µÚ¶þ¾üÒ½´óѧ¡¢¸£½¨Ò½¿Æ´óѧ¡¢¸£½¨ÖÐҽѧԺµÈҽѧԺѧÉúµÄ½Ìѧ¡¢ÊµÏ°¼°¼ûÏ°ÈÎÎñ£¬²¢ÔÚ½Ìѧ»î¶¯Öлý¼«Ì½Ë÷ºÍÔËÓÃÖС¢Ó¢Ë«Óï½Ìѧ£¬»ñµÃÁËÏà¹ØѧУºÍѧÉúµÄºÃÆÀ£»ËùÖ¸µ¼µÄÑо¿Éú·¢±íÁËһϵÁиßˮƽµÄSCIÊÕ¼ÂÛÎÄ¡£

·¢±íµÄÂÛÎÄ£º
1¡¢Kuang P£¬ Zhao W£¬ Su W£¬ Zhang Z£¬ Zhang L£¬ Liu J£¬ Ren G£¬ Yin Z*£¬ Wang X.18¦Â-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice.Int J Cancer. 2012 Sep 18. doi: 10.1002/ijc.27852. [Epub ahead of print]
2¡¢Zhao W£¬ Su W£¬ Kuang P£¬ Zhang L£¬ Liu J£¬ Yin Z*£¬ Wang X. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma. Int J Oncol. 201241(2):457-64.
3¡¢Zhou C S£¬ Yin Z Y£¨¹²µÚÒ»×÷Õߣ©£¬ Zhao W X£¬ Zhang L£¬ You J Y£¬ Su W X£¬ Fan J£¬ Wang X M: Bear bile inhibits the immunosuppression activity of hepatic stellate cells in vivo. Hepatogastroenterology 2012£¬ 59(117):1529-1536.
4¡¢Zhao Z£¬ Huang D£¬ Yin Z(¹²µÚÒ»×÷Õß)£¬ Chi X£¬ Wang X£¬ Gao J. Magnetite nanoparticles as smart carriers to manipulate the cytotoxicity of anticancer drugs: magnetic control and pH-responsive release. J Mater Chem 2012 [Epub ahead of print] DOI:10.1039/C2JM31692G.
5¡¢Zhao W£¬ Ren G£¬ Zhang L£¬ Zhang Z£¬ Liu J£¬ Kuang P£¬ Yin Z*£¬ Wang X. Efficacy of Mesenchymal Stem Cells Derived from Human Adipose Tissue in inhibition of hepatocellular carcinoma Cells in vitro. Cancer Biother Radio. 2012 Aug 23. [Epub ahead of print]
6¡¢Zhou J£¬ Zhao Y£¬ Wang J£¬ Zhang S£¬ Liu Z£¬ Zhen M£¬ Liu Y£¬ Liu P£¬ Yin Z£¬ Wang X. Therapeutic angiogenesis using basic fibroblast growth gactor in combination with a collagen matrix in chronic hindlimb ischemia. scientific world journal 2012:652794.
7¡¢Chi XQ£¬ Huang DT£¬ Zhao ZH£¬ Zhou ZJ£¬ Yin ZY£¬ Gao JH. Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials 201233£¨1£©£º189-206.
8¡¢Zhao Y£¬ Zhang Z£¬ Wang J£¬ Yin P£¬ Wang Y£¬ Yin Z£¬ Zhou J£¬ Xu G£¬ Liu Y£¬ Deng Z£¬ Zhen M£¬ Cui W£¬ Liu Z. Preparation of decellularized and crosslinked artery patch for vascular tissue-engineering application. J Mater Sci Mater Med 201122(6):1407-17.
9¡¢Deng ZG£¬ Zhou JTY£¬ Yin ZY*£¬ Peng YY£¬ Wang FQ£¬Wang XM. Continuous Regional Arterial Infusion Therapy via Drug Delivery Catheter for Severe Acute Pancreatitis with Abdominal Compartment Syndrome. World Journal of Gastroenterology 2011 17(44): 4911¨C4916.
10¡¢Ding F£¬ Yin Z£¬ Wang H R: Ubiquitination in Rho signaling. Curr Top Med Chem 2011£¬ 11(23):2879-2887.
11¡¢Zhao W£¬ Zhang L£¬ Yin Z*£¬ Su W£¬ Ren G£¬ Zhou C£¬ You J£¬ Fan J£¬ Wang X. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer **(11):2651-61.
12¡¢Deng Z£¬ Yin Z*£¬ Chen S£¬ Peng Y£¬ Wang F£¬ Wang X. Metastatic splenic fetoprotein-producing adenocarcinoma: Report of a case. Surg Today. 201141(6):854-8.
13¡¢Zhao Y£¬ Liu Z£¬ Pan C£¬ Li Z£¬ Zhou J£¬ Wang J£¬ Yin Z£¬ Wang X. Preparation of gelatin microspheres encapsulated with bFGF for therapeutic angiogenesis in a canine ischemic hind limb.J Biomater Sci Polym Ed 201122(4-6):665-82.
14¡¢Yin ZY*£¬ Li N£¬ Wang XM£¬ Ni XD£¬ Jiang F£¬ Li YS and Li JS. Immunological protection of liver graft on simultaneous transplanted small bowel in pigs. Hepatobiliary and Pancreatic Diseases International.2009 8(4):363-369.
15¡¢Hong ZF£¬ Huang XJ£¬ Yin ZY£¬ Zhao WX£¬ Wang X.M. Immunosuppressive function of bone marrow mesenchymal stem cells on acute rejection of liver allografts in rats. Transplant Proc 2009 41:403¨C409.(SCI)
16¡¢Wang XM£¬ Yin ZY£¬ Yu RX£¬ Peng YY£¬ Liu PG£¬ Wu GY. Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy. World J Gastroenterol 2008 14(4): 518-523
17¡¢Yin ZY*£¬ et al. Co-transplanted hepatic stellate cells enhance vascularization of islet allografts. Microsurgery 2007£»27(4):324-7.
18¡¢Yin ZY*£¬ et al. intracellular adhesion molecule 1 (ICAM-1) is an important factor in hepatic stellate cells induced allo-islet tolerance. Microsurgery 2007 27(4):328-32.
19¡¢Lina Lu£¬ Cheng-Hsu Chen£¬ Zhenyu Yin£¬ John J. Fung£¬ Liang-Mou Kuo£¬ Shiguang Qian¡£Liver Tissue Cells Inhibit Immune Responses by Inducing T Cell Apoptosis: An Application in Islet Transplantation. Clinical Immunology£¬ 2007 123 : S15-S15.
20¡¢Shiguang Qian£¬ Guoping Jiang£¬ Zhenyu Yin£¬ John J. Fung£¬ Liang-Mou Kuo£¬ Lina Lu. Hepatic Stellate Cells Expand CD4+CD25+Foxp3+ Tregs and Prevent Rejection of Allogeneic Islet Transplants. Clinical Immunology 2007 123: S132-S132.
21¡¢Yin ZY*£¬ Zhang H£¬ Fung JJ£¬ Qian SG£¬ Lu LN. Inhibition of B7-H1 expression on tissue cells by antisense ODN abrogates their immune suppressive activity. AMERICAN JOURNAL OF TRANSPLANTATION.2007 7( Suppl. 2):333.(SCI)
22¡¢Yin ZY*£¬ Chen CH£¬ Zhang H£¬ Fung JJ£¬ Lu L£¬ Qian SG. Immune inhibitory activity of liver stellate cells is mediated by inducible expression of B7-H1. American Journal of Transplantation 2006 6(l) :2:893. (SCI) WORLD TRANSPLANT CONGRESS.
23¡¢Yin ZY*£¬Wang XM£¬Li N£¬ N XD£¬ et al. Immunologic advantage on small bowel graft induced by simultaneous transplanted liver in auxiliary liver\small bowel transplantation in pigs. American Journal of Transplantation 2006 6(l) :2:893. (SCI) WORLD TRANSPLANT CONGRESS.
24¡¢Yin Z*£¬ et al. Immunological advantage on small bowel graft induced by simultaneously transplanted liver in porcine auxiliary liver/small bowel transplantation. Transplant Proc 2006 38(10): 3251-2.
25¡¢Yin ZY*£¬ Wang XM£¬ Ni XD£¬ et al. Auxiliary en-bloc liver-small bowel transplantation with partial pancreas preservation in pigs. World Journal of Gastroenterology. World Journal of Gastroenterology 2004 10(10): 1499-1503.
26¡¢Yin ZY*£¬ Ni XD£¬ Jiang F£¬ et al. Modified technique for combined liver-small bowel transplantation in pigs. World Journal of Gastroenterology 2003 9(7):1625-1628.
27¡¢Yin ZY*£¬ Wang XM£¬ Yu RX£¬ et al. Total vascular exclusion technique for resection of hepatocellular carcinoma. World Journal of Gastroenterology 20039(10):2194-2197.
28¡¢ËÕάѩ£¬ ÕÔÎÄÐ㣬 ¿õÅô껣¬ ÕÅÀÚ£¬ Öܳ¤Éý£¬ ÒüÕðÓ ÍõЧÃñ. »î»¯µÄ¸ÎÐÇ״ϸ°û´Ù½øµ÷½ÚÐÔTϸ°ûµÄ±í´ï¡£Öлª¸Îµ¨Íâ¿ÆÔÓÖ¾. 20124:305-309¡£
29¡¢ÒüÕðÓÍõ¸¶Ç¿£¬ÅíÓÑÔµµÈ¡£³¬ÉùÈ黯ÎüÒýµ¶ÁªºÏ³¬Éùµ¶ÔÚ¸¹Ç»¾µ¸ÎÖ×ÁöÇгýÊõÖеÄÓ¦Óá£Öлª¸Îµ¨Íâ¿ÆÔÓÖ¾£¬2011£¬17£¨12£©£º1013-1014¡£
30¡¢Öܳ¤Éý£¬ÒüÕðÓÕÔÎÄÐ㣬ËÕάѩ£¬ÓÈ¿¡Ó£¬ÕÅÀÚ£¬ÍõЧÃñ¡£Ðܵ¨¶Ô¸ÎÐÇ״ϸ°ûÃâÒßѧÌØÐÔÓ°ÏìµÄÑо¿¡£ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2011 10(26): 2251-2254¡£
31¡¢ÕÅÀÚ£¬ ÕÔÎÄÐ㣬 ÒüÕðÓ ËÕάѩ£¬ Öܳ¤Éý£¬ ÍõЧÃñ¡£ »î»¯µÄ¸ÎÐÇ״ϸ°ûÔÚÖ×Áö΢»·¾³ÖеÄÃâÒßµ÷½Ú×÷ÓÃ.Öлª¸Îµ¨Íâ¿ÆÔÓÖ¾. 201117(6):501-506.
32¡¢ÒóÀò²¨£¬ ÕÔÎÄÐ㣬 ÒüÕðÓ ÑîÖÐÃÈ£¬ ÕÅÇí£¬ ÍõЧÃñ¡£ÌåÄÚÍâÈËÖ¬·¾¼ä³äÖʸÉϸ°ûÏò¸ÎÑùϸ°û·Ö»¯µÄʵÑéÑо¿¡£Öлª¸Îµ¨Íâ¿ÆÔÓÖ¾. 201117(4):322-327
33¡¢Íõ¸¶Ç¿£¬ÒüÕðÓÅíÓÑÔµ£¬µËÖ¾¸Õ£¬ÁõÕù½ø£¬ÍõЧÃñ.¸ÎÄÚµ¨¹ÜÉñ¾­ÄÚ·ÖÃÚ°©¶þÀý±¨¸æ.Öлª¸Îµ¨Íâ¿ÆÔÓÖ¾£¬2010£¬16£¨11£©£º888£­889.
34¡¢ÅíÓÑÔµ ÑÏÎä ²ÌÏþÀ¤ ÒüÕðÓî*¡£PNP-CDÈÚºÏ×Ôɱ»ùÒòϵͳ¶Ô¸Î°©Ï¸°ûɱÉË×÷ÓõÄʵÑéÑо¿¡£Öлª¸ÎÍâ¿ÆÔÓÖ¾2010£¬ 16(8)£º624£­627.
35¡¢ÅíÓÑÔµ£¬ÒüÕðÓî*£¬ÍõЧÃñ£¬ÓÚÈÊÏ飬µËÖ¾¸Õ£¬Íõ¸¶Ç¿¡£½âÆÊÐÔ¸ÎÔàÇøÓòѪÁ÷×è¶ÏÔڸΰ©ÇгýÊõÖеÄÓ¦Óà ¸Îµ¨Íâ¿ÆÔÓÖ¾2010£¬18£¨1£©£º22-24¡£
36¡¢Áõƽ¹û£¬ ÍõЧÃñ£¬ ÒüÕðÓ ËÕÓÀ½Ü£¬ ÕÅÅô£¬ ţСÇ࣬ ¹ȫÒâ¡£¸¹Ç»¾µÆ¢ÇгýÖÎÁÆÌØ·¢ÐÔѪС°å¼õÉÙÐÔ×Ïñ°ÁÆЧ¼°¹Û²âÖ¸±ê£¬ÖйúÆÕͨÍâ¿ÆÔÓÖ¾ 2009 £»18 (9): 948-950¡£
37¡¢ÒüÕðÓ ÍõЧÃñ£¬ ½¯¹úƽ£¬ ÂÀÀöÄÈ£¬ Ǯʫ¹â¡£Ð¡Êó×ÔÌå¸ÎÔàÐÇ״ϸ°ûÁªºÏͬÖÖÒìÌåÒȵºÏ¸°ûÒÆÖ²ÑÓ³¤ÒÆÖ²Îï´æ»îʱ¼äµÄÑо¿¡£ÖлªÆ÷¹ÙÒÆÖ²ÔÓÖ¾ 2009£»30£¨2£©£º94-96¡£
38¡¢ÒüÕðÓÍõЧÃñ£¬ÀîÄþ£¬ÀîÓ×Éú£¬ÄßС¶¬£¬½¯·å£¬Àè½éÊÙ¡£¸¨ÖúÐԸγ¦ÁªºÏÒÆÖ²ÊõºóÅųⷴӦµÄ¼à²â¡£ÖлªÎ¸³¦Íâ¿ÆÔÓÖ¾ 2009£»12£¨4£©£º23-26¡£
39¡¢ºéÔÙ·¢£¬»ÆС½ø£¬ÒüÕðÓÍõЧÃñ¡£¹ÇËè¼ä³äÖʸÉϸ°ûµÄÌØÐÔ¡£Öлª¸ÎÔಡÔÓÖ¾200917(1):53-8¡£
40¡¢ÓàÇ¿·æ£¬ Öܽ£Òú£¬ ÒüÕðÓ ÕÔÎÄÐ㣬 ÍõЧÃñ.ÅßÌ¥¸Î¸Éϸ°û·ÖÀë¼ø¶¨ÓëÒÆÖ²ÖÎÁÆÂãÊó¼±ÐÔ¸ÎËðÉË.ÖлªÆÕͨÍâ¿ÆÔÓÖ¾ 2009 24(5): 550-553
41¡¢Íõ¸¶Ç¿ ÒüÕðÓî*. ¸ÎÐÇ״ϸ°ûµÄÃâÒßѧ¹¦ÄÜÑо¿½øÕ¹. ¸Îµ¨Íâ¿ÆÔÓÖ¾200917(1): 69-71¡£
42¡¢ÒüÕðÓÍõЧÃñ£¬ÀîÄþ£¬ÀîÓ×Éú£¬ÄßС¶¬£¬½¯·å£¬Àè½éÊÙ¡£Öí¸Î³¦ÁªºÏÒÆÖ²ÃâÒßÄÍÊܵÄʵÑéÑо¿¡£ÖлªÏû»¯Íâ¿ÆÔÓÖ¾ 2008£»7£¨6£©£º426-428¡£
43¡¢ºéÔÙ·¢£¬ »ÆС½ø£¬ ÒüÕðÓ ÍõЧÃñ. ¹ÇËè¼ä³äÖʸÉϸ°ûÓÕµ¼¸ÎÒÆÖ²ÊõºóÃâÒßÄÍÊܵÄÑо¿. ¸Îµ¨Íâ¿ÆÔÓÖ¾2008 16(5):374-379¡£
44¡¢ÒüÕðÓÍõЧÃñµÈ¡£Öí¸¨ÖúÐÔ´øÒÈÍ·¼°Ê®¶þÖ¸³¦¸Î³¦ÁªºÏÒÆÖ²µÄÑо¿¡£ÖлªÊµÑéÍâ¿ÆÔÓÖ¾ 2005£»22£¨5£©£º555-557¡£
45¡¢ÒüÕðÓµÈ¡£Öí¸ÎС³¦ÁªºÏÒÆÖ²¶¯ÎïÄ£Ð͵Ľ¨Á¢¡£ÖлªÆ÷¹ÙÒÆÖ²ÔÓÖ¾ 2004£»25£º86-89¡£


½ÌÓý±³¾° :
ÒüÕðÓÄУ¬1969Äê3ÔÂÉú£¬ºþ±±Î人ÈË£¬Öйú¹²²úµ³µ³Ô±¡£²©Ê¿£¨MD£¬PhD£©£¬ÁôÃÀ²©Ê¿ºó£¬½ÌÊÚ£¬Ö÷ÈÎҽʦ£¬²©Ê¿Ñо¿Éúµ¼Ê¦£¬¸Îµ¨Íâ¿ÆÖ÷ÈΣ¬ÏÃÃÅÊаμâÈ˲Å£¬ÏÃÃÅÊÐÖصãÒý½øÈ˲Å£¬ÏÃÃÅÊÐÁôѧ¹é¹úÈ˲Å£¬ÏÃÃÅÊÐÏû»¯ÏµÍ³Ö×Áöת»¯Ò½Ñ§ÖصãʵÑéÊÒ³£Îñ¸±Ö÷ÈΣ¬¸£½¨Ê¡¼°ÏÃÃÅÊÐÎÀÉúºó±¸È˲ŵÈ¡£
Ö÷ÒªµÄѧϰºÍ¹¤×÷¾­Àú£º
1988.09£­1993.07£ºÄϾ©´óѧҽѧԺÁÙ´²Ò½Ñ§±¾¿ÆÉú£»
1993.09£­1995.07£ºÄϾ©´óѧҽѧԺ˶ʿÑо¿Éú£¨ÆßÄêÖÆ£©£»
2001.09£­2004.07£ºÄϾ©´óѧҽѧԺ²©Ê¿Ñо¿Éú£¬µ¼Ê¦ÎªÖøÃûµÄÍâ¿Æѧ¼Ò¡¢Öйú¹¤³ÌԺԺʿÀè½éÊÙ½ÌÊÚ£»
2005.04£­2006.02:¹ú¼Ò³ö¹úÁôѧ»ù½ðÈ«¶î×ÊÖú(2Äê)£¬¸°ÃÀ¹úÆ¥×ȱ¤´óѧҽѧÖÐÐÄ£¨UPMC£¬UniversityofPittsburghMedicalCenter£©£¬ÔÚÈ«Çò×îÖøÃûµÄSTARZLÆ÷¹ÙÒÆÖ²Ñо¿Ëù¼°¸ÎÔàÖÐÐÄ×ö¸ß¼¶·ÃÎÊѧÕß¡£
2006.02£­2007.04£ºÔÚ¿ËÀï·òÀ¼ÁÙ´²Ò½Ñ§ÖÐÐÄ£¨CCF£¬ClevelandClinicFoundation£©¸Îµ¨Íâ¿ÆÖÐÐļ°ÒÆÖ²ÖÐÐÄ´ÓÊÂÒÆÖ²ÃâÒß²©Ê¿ºóÑо¿¼°ÁÙ´²ÑÐÐÞ¡£
1999.02£ºÏÃÃÅ´óѧ¸½ÊôÖÐɽҽԺ¸Îµ¨Íâ¿ÆÖ÷ÖÎҽʦ£»
2004.07£ºÏÃÃÅ´óѧ¸½ÊôÖÐɽҽԺ¸Îµ¨Íâ¿Æ¸±Ö÷ÈÎҽʦ£»
2007.04£ºÏÃÃÅ´óѧ¸½ÊôÖÐɽҽԺ¸Îµ¨Íâ¿ÆÖ÷ÈΡ£
2009.09:ÏÃÃÅ´óѧ½ÌÊÚ£»
2011.09£ºÏÃÃÅ´óѧ¸½ÊôÖÐɽҽԺ¸Îµ¨Íâ¿ÆÖ÷ÈÎҽʦ£»
2012.05:ÏÃÃÅ´óѧ²©Ê¿Ñо¿Éúµ¼Ê¦£»

ÁÙ´²¹¤×÷£º